Roswell Park Cancer Institute
Clinical trials sponsored by Roswell Park Cancer Institute, explained in plain language.
-
Experimental combo vaccine and drugs show promise for blood cancers
Disease control CompletedThis early-phase trial tested a combination of a cancer vaccine (CDX-1401), an immune booster (poly ICLC), chemotherapy (decitabine), and an immunotherapy drug (nivolumab) in 8 people with myelodysplastic syndrome (MDS) or low-blast acute myeloid leukemia (AML). The main goal was…
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New cocktail shows promise for Tough-to-Treat colorectal cancer
Disease control CompletedThis study tested a combination of three drugs (TAS-102, irinotecan, and bevacizumab) in 42 people with advanced colorectal cancer that had already been treated and spread or couldn't be removed. The goal was to see if this mix could slow cancer growth better than standard treatm…
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New vaccine trains body to attack cancer cells in neuroendocrine tumors
Disease control CompletedThis early-phase study tested a vaccine called SurVaxM in 19 people with neuroendocrine tumors that had spread. The vaccine teaches the immune system to recognize and attack tumor cells. The main goals were to check safety and see if the vaccine triggers an immune response.
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New Light-Measuring tech could make cancer therapy safer and more precise
Disease control CompletedThis early-phase study tested a system that measures how much laser light reaches tumors during photodynamic therapy (PDT) in people with mesothelioma, non-small cell lung cancer, or other cancers that spread to the lining of the lungs. Nine participants received a light-activate…
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
New drug combo shows promise against advanced liver cancer
Disease control CompletedThis study tested a combination of two drugs, sorafenib and pembrolizumab, in 37 adults with advanced liver cancer that had spread. The goal was to see if the combination could shrink tumors and help patients live longer. The approach uses one drug to block cancer cell growth and…
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 04, 2026 16:17 UTC
-
New device spots dangerous IV leaks before nurses can
Prevention CompletedThis study tested a device called ivWatch that monitors IV sites in cancer patients getting chemotherapy. The goal was to see if it could detect when medication leaks out of the vein into surrounding tissue before a nurse notices. Over 2,400 patients took part, and the device may…
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Prevention
Last updated May 15, 2026 11:57 UTC
-
Could a vaccine stop lung cancer before it starts?
Prevention CompletedThis early-phase trial tested a vaccine called CIMAvax-EGF in 20 people at high risk for lung cancer or survivors at risk of recurrence. The vaccine works by helping the body make antibodies against a protein (EGF) that can fuel cancer growth. Researchers measured immune response…
Phase: EARLY_PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Prevention
Last updated May 05, 2026 11:56 UTC
-
Could an antidepressant ease cancer pain? new study investigates
Symptom relief CompletedThis study looked at whether adding venlafaxine (a medicine often used for depression) to standard painkillers like gabapentin, methadone, and oxycodone can better manage pain in people with head and neck cancer who are getting chemotherapy and radiation. About 62 adults with sta…
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated May 13, 2026 16:04 UTC
-
Vapers tested: which E-Liquid delivers more nicotine?
Knowledge-focused CompletedThis study looked at how nicotine salt-based vaping products compare to free-base nicotine e-liquids. Fifteen daily vapers had their blood nicotine levels measured and reported how harsh or satisfying each product felt. The goal was to understand the abuse potential of different …
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated May 17, 2026 03:30 UTC
-
Scientists uncover clues to Tamoxifen's inner workings in breast cancer
Knowledge-focused CompletedThis study looked at how the breast cancer drug tamoxifen interacts with certain proteins inside tumor cells. Researchers studied 59 women with a common type of breast cancer to better understand why some tumors respond to tamoxifen and others do not. The goal is to use this know…
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated May 17, 2026 03:27 UTC